Modulating inappropriate
T cell activity
Modulating inappropriate T cell activity is essential for addressing the underlying cause of many allergic and autoimmune diseases. However, typical drug screening approaches have a number of limitations:
- Can result in missing or screening out of potentially promising molecules
- Can result in initial selection of molecules that ultimately lack desired T cell-modulating activity
- Slow and expensive process